Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis.
about
Current clinical application of serum biomarkers to detect ovarian cancerThe emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomasComparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.Comparison of HE4, CA125, and ROMA Diagnostic Accuracy: A Prospective and Multicenter Study for Chinese Women With Epithelial Ovarian Cancer.Adenoviral-delivered HE4-HSV-tk sensitizes ovarian cancer cells to ganciclovirCirculating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis.Determination of reference intervals of serum levels of human epididymis protein 4 (HE4) in Chinese womenAnalysis of falsely elevated risk of ovarian malignancy algorithm in women with ovarian endometrioma.Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.Frozen section in gynaecology: uses and limitations.The role of human epididymis protein 4 in the diagnosis of epithelial ovarian cancer.Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspectiveThe role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review.Evaluating the clinical significances of serum HE4 with CA125 in peritoneal tuberculosis and epithelial ovarian cancer.Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer.Serum human epididymis protein 4 levels in colorectal cancer patients.HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer.
P2860
Q26768709-6D5ED6AF-7BDC-4FC0-A170-9D09C83FC5D5Q26992102-BCA7B437-D8AB-4617-AE00-1E31DFFF3979Q33733786-29D63600-C370-4D19-813E-C09CAD938AAEQ34675023-B7131E5C-A4B7-4081-936B-43F9AD343985Q35634132-A6BE3864-0B0D-478E-999A-5CBD6B2F9B55Q36037774-1B2E9858-1765-4281-AEAF-D20DEE64CE70Q36262845-052B0935-CEB8-4808-8323-752A098DC5FDQ37121126-1280BB59-0606-4F49-AF81-E631381187AFQ37406838-CA94F963-46C5-492A-AA3B-0A185DB04001Q38177702-F87ADA93-DA13-4DF2-AD06-664278C4FED8Q38388103-02EF3660-7066-4908-B214-4D521F6750EFQ38649539-87FC9AF3-0227-4A5B-92FA-54691849A82FQ38653169-0E0DD706-F2F4-44BB-B37C-2634AE02C312Q40212320-F2479D1E-C399-4161-8F15-3FE30DAA93AFQ47094357-F412612A-93B6-46F2-AFD0-3302C569BDB6Q47819596-2DE3990F-56F0-457F-A288-0C02C36E9E2EQ51091632-699E3397-DEC4-4721-9309-892A02A2C23F
P2860
Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Human epididymis protein 4 for ...... atic review and meta-analysis.
@ast
Human epididymis protein 4 for ...... atic review and meta-analysis.
@en
Human epididymis protein 4 for ...... atic review and meta-analysis.
@nl
type
label
Human epididymis protein 4 for ...... atic review and meta-analysis.
@ast
Human epididymis protein 4 for ...... atic review and meta-analysis.
@en
Human epididymis protein 4 for ...... atic review and meta-analysis.
@nl
prefLabel
Human epididymis protein 4 for ...... atic review and meta-analysis.
@ast
Human epididymis protein 4 for ...... atic review and meta-analysis.
@en
Human epididymis protein 4 for ...... atic review and meta-analysis.
@nl
P2093
P31
P1476
Human epididymis protein 4 for ...... atic review and meta-analysis.
@en
P2093
JiaYing Lin
JinBao Qin
Voramon Sangvatanakul
P356
10.1016/J.EJOGRB.2012.10.036
P577
2012-12-07T00:00:00Z